These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


403 related items for PubMed ID: 10571598

  • 1. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract.
    Nardone G, Rocco A, Balzano T, Budillon G.
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1429-36. PubMed ID: 10571598
    [Abstract] [Full Text] [Related]

  • 2. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract.
    Orsi P, Guatti-Zuliani C, Okolicsanyi L.
    Dig Liver Dis; 2001 May; 33(4):330-4. PubMed ID: 11432511
    [Abstract] [Full Text] [Related]

  • 3. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia.
    Junquera F, Saperas E, Videla S, Feu F, Vilaseca J, Armengol JR, Bordas JM, Piqué JM, Malagelada JR.
    Am J Gastroenterol; 2007 Feb; 102(2):254-60. PubMed ID: 17311647
    [Abstract] [Full Text] [Related]

  • 4. Octreotide for recurrent intestinal bleeding due to ventricular assist device.
    Coutance G, Saplacan V, Belin A, Repessé Y, Buklas D, Massetti M.
    Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):350-2. PubMed ID: 24585917
    [Abstract] [Full Text] [Related]

  • 5. Octreotide long-active release in the treatment of gastrointestinal bleeding due to vascular malformations: Cost-effectiveness study.
    Klímová K, Padilla-Suárez C, Giménez-Manzorro Á, Pajares-Díaz JA, Clemente-Ricote G, Hernando-Alonso A.
    Rev Esp Enferm Dig; 2015 Feb; 107(2):79-88. PubMed ID: 25659389
    [Abstract] [Full Text] [Related]

  • 6. [Octreotide and angiodysplasia].
    Fernández Salazar LI, de la Calle Valverde F, González Hernández JM.
    Gastroenterol Hepatol; 2004 Nov; 27(9):558-9. PubMed ID: 15544743
    [No Abstract] [Full Text] [Related]

  • 7. [Octreotide in the treatment of angiodysplasia in patients with advanced chronic renal failure].
    Rivera M, Lucero J, Guerrero A, Márquez JL, Montes R, Suñer M, Ruiz A, Valdivia MA, Mateos J.
    Nefrologia; 2005 Nov; 25(3):332-5. PubMed ID: 16053016
    [Abstract] [Full Text] [Related]

  • 8. Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases.
    Nardone G, Compare D, Scarpignato C, Rocco A.
    Dig Liver Dis; 2014 Aug; 46(8):688-94. PubMed ID: 24893688
    [Abstract] [Full Text] [Related]

  • 9. Comparison of argon plasma coagulation in management of upper gastrointestinal angiodysplasia and gastric antral vascular ectasia hemorrhage.
    Chiu YC, Lu LS, Wu KL, Tam W, Hu ML, Tai WC, Chiu KW, Chuah SK.
    BMC Gastroenterol; 2012 Jun 09; 12():67. PubMed ID: 22681987
    [Abstract] [Full Text] [Related]

  • 10. Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation.
    Classen CF, Haffner D, Hauenstein C, Wolf R, Kyank U.
    BMJ Case Rep; 2011 Aug 17; 2011():. PubMed ID: 22688939
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Medical and endoscopic therapies for angiodysplasia and gastric antral vascular ectasia: a systematic review.
    Swanson E, Mahgoub A, MacDonald R, Shaukat A.
    Clin Gastroenterol Hepatol; 2014 Apr 17; 12(4):571-82. PubMed ID: 24013107
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients?
    Iannone A, Principi M, Barone M, Losurdo G, Ierardi E, Di Leo A.
    Clin Res Hepatol Gastroenterol; 2016 Sep 17; 40(4):373-7. PubMed ID: 27595456
    [Abstract] [Full Text] [Related]

  • 16. Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapy.
    Blich M, Fruchter O, Edelstein S, Edoute Y.
    Scand J Gastroenterol; 2003 Jul 17; 38(7):801-3. PubMed ID: 12889571
    [Abstract] [Full Text] [Related]

  • 17. [Somatostatin analogues in the treatment of bleeding GI-angiodysplasias].
    Boesby L, Christensen NJ, Kristensen LO.
    Ugeskr Laeger; 2008 Mar 10; 170(11):958. PubMed ID: 18397628
    [Abstract] [Full Text] [Related]

  • 18. Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine.
    Rossini FP, Arrigoni A, Pennazio M.
    Am J Gastroenterol; 1993 Sep 10; 88(9):1424-7. PubMed ID: 8362842
    [Abstract] [Full Text] [Related]

  • 19. Role of Octreotide in Pediatric Gastrointestinal Bleeding Secondary to Angiodysplasia in Children With Right Heart Failure.
    Puri K, Caldwell RL, Molleston JP.
    J Pediatr Gastroenterol Nutr; 2018 Feb 10; 66(2):e41-e44. PubMed ID: 28614113
    [Abstract] [Full Text] [Related]

  • 20. Gastric angiodysplasia in a child with Bernard-Soulier syndrome: efficacy of octreotide in long-term management.
    Kaya Z, Gürsel T, Dalgic B, Aslan D.
    Pediatr Hematol Oncol; 2005 Feb 10; 22(3):223-7. PubMed ID: 16020106
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.